These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cardiac amyloidosis. Kingman A; Pereira NL J S C Med Assoc; 2001 May; 97(5):201-6. PubMed ID: 11381776 [TBL] [Abstract][Full Text] [Related]
27. [Primary cardiac amyloidosis -- condition which can be diagnosed by a cardiologist]. Zielińska M; Koniarek W; Kaczmarek K; Maciejewski M; Wagrowska-Danilewicz M; Goch JH Kardiol Pol; 2006 May; 64(5):517-21. PubMed ID: 16752338 [TBL] [Abstract][Full Text] [Related]
28. Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma. Carrizales-Sepúlveda EF; Ordáz-Farías A; Vera-Pineda R; Benavides-González MA; Flores-Ramírez R Am J Case Rep; 2017 Jul; 18():790-793. PubMed ID: 28701686 [TBL] [Abstract][Full Text] [Related]
30. Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis. Roslan A; Kamsani SH; Nay TW; Tan KL; Hakim N; Tan AM; Megat Samsudim WN; Tan KL; Jauhari AT; Krishnan M; Leong D; Supramaniam T; Tan LK; Nuruddin AA Med J Malaysia; 2018 Dec; 73(6):388-392. PubMed ID: 30647209 [TBL] [Abstract][Full Text] [Related]
32. Early cardiac involvement in senile systemic amyloidosis: a case report. Yamano M; Azuma A; Yazaki M; Ikeda S; Sawada T; Matsubara H Amyloid; 2008 Mar; 15(1):54-9. PubMed ID: 18266122 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis. Pelosi F; Capehart J; Roberts WC Am J Cardiol; 1997 Feb; 79(4):532-5. PubMed ID: 9052371 [TBL] [Abstract][Full Text] [Related]
34. Deposit Diseases as Differential Diagnosis of Left Ventricular Hypertrophy in Patients with Heart Failure and Preserved Systolic Function. Fernandes F; Antunes MO; Hotta VT; Rochitte CE; Mady C Arq Bras Cardiol; 2019 Nov; 113(5):979-987. PubMed ID: 31800724 [No Abstract] [Full Text] [Related]
35. Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis. Bucciarelli-Ducci C; Locca D; Barbeau G; Prasad SK Eur Heart J; 2007 May; 28(10):1186. PubMed ID: 17121755 [No Abstract] [Full Text] [Related]
36. Pulmonary alveolar-septal amyloidosis presenting as heart failure with unilateral pleural effusion: a case report. Liu YY; Lee YC; Chou TY; Perng RP Zhonghua Yi Xue Za Zhi (Taipei); 1999 Nov; 62(11):838-43. PubMed ID: 10575815 [TBL] [Abstract][Full Text] [Related]
37. Cardiac amyloidosis. Diagnosis by transvenous endomyocardial biopsy. Schroeder JS; Billingham ME; Rider AK Am J Med; 1975 Aug; 59(2):269-73. PubMed ID: 1098458 [TBL] [Abstract][Full Text] [Related]
38. Management of Cardiac Symptoms in Amyloidosis. King P; Kates AM Am J Med; 2022 Apr; 135 Suppl 1():S9-S12. PubMed ID: 35235819 [TBL] [Abstract][Full Text] [Related]
39. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis. Perlini S; Mussinelli R; Salinaro F Curr Heart Fail Rep; 2016 Dec; 13(6):267-272. PubMed ID: 27900617 [TBL] [Abstract][Full Text] [Related]
40. Amyloidosis: recognition, confirmation, prognosis, and therapy. Gertz MA; Lacy MQ; Dispenzieri A Mayo Clin Proc; 1999 May; 74(5):490-4. PubMed ID: 10319082 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]